US FDA/CFSAN - Implementation of FDA's Current Good Manufacturing Practices for Dietary Supplements
October 24, 2007
IFR
- FDA has no preconceived notions of what would constitute a successful petition. As we gain experience in this area:
- FDA will issue guidance on the information and type of data it recommends be included in the citizen petition.
- The guidance will include our recommendations about the type of information that a manufacturer could obtain about each supplier that it intends to use for the ingredient and its specifications that would assist us in evaluating the petition.